TraceLink’s MINT Named “Supply Chain Transparency Solution of the Year” in 2025 SupplyTech Breakthrough Awards
The award recognizes MINT for enabling real-time, end-to-end visibility across critical supply…
XTEND Reality Inc. Debuts New U.S. Headquarters and Drone Production Facility in Tampa, Driving Innovation and National Security
New facility strengthens America's domestic drone production capacity while bringing high-tech jobs…
Algorand Foundation and Paycode Announce Partnership to Expand Financial Inclusion on Blockchain
New partnership aims to bring secure, offline-first digital payment infrastructure worldwide SINGAPORE,…
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the…
Ares Management Acquires Minority Stake in Plenitude for 2 Billion
LONDON & MILAN--(BUSINESS WIRE)--Ares Management Corporation (“Ares”) (NYSE: ARES), a leading global…
Amrize Debuts as Independent, Publicly Traded Company
100% spin-off from Holcim complete Amrize begins trading on NYSE and SIX…
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
Inozyme Pharma, Inc. Announces Postponement of 2025 Annual Meeting of Stockholders
June 20, 2025 17:00 ET Â | Source: Inozyme Pharma Inc. BOSTON, June…